InvestorsHub Logo
Followers 15
Posts 1469
Boards Moderated 0
Alias Born 01/22/2017

Re: None

Wednesday, 10/04/2023 10:20:24 AM

Wednesday, October 04, 2023 10:20:24 AM

Post# of 6726
News is deceiving , article title sounds bad but is really good for MEDIF
Here is the link , but I pasted highlights below.
https://www.otcmarkets.com/stock/MEDIF/news/MediPharm-Labs-Settles-an-Outstanding-Claim-for-9M?id=415985

Settlement Highlights

Upon the acquisition of HEXO Corp. by Tilray Brands (NASDAQ: TLRY), MediPharm and Tilray sought a resolution that was favorable to each party and established a long-term supply relationship in connection with the settlement agreement. Under the agreement, MediPharm will receive a total value consideration of $9 million including:

$3 million immediate cash payment;

$4.5 million in common shares of Tilray;

$1 million in Tilray cannabis products, including high-quality flower and extractable bio-mass; and

$500,000 supply agreement to provide Tilray with MediPharm products and services over four years.

This long-term supply agreement will allow MediPharm to establish a positive ongoing business relationship with a global leader in the cannabis industry. The deal is also expected to benefit Tilray through access to MediPharm's unique pharmaceutical products and services both domestically and internationally, including products produced under the company's US FDA Foreign Drug Site registration and Canadian Pharmaceutical Drug Establishment License.